Prilosec: Effective Prescription-Strength Acid Control for GERD
| Product dosage: 10mg | |||
|---|---|---|---|
| Package (num) | Per cap | Price | Buy |
| 90 | $0.51 | $45.58 $45.58 (0%) | 🛒 Add to cart |
| 180 | $0.45 | $91.16 $80.84 (11%) | 🛒 Add to cart |
| 270 | $0.43 | $136.74 $116.10 (15%) | 🛒 Add to cart |
| 360 | $0.42
Best per cap | $182.32 $151.36 (17%) | 🛒 Add to cart |
| Product dosage: 20mg | |||
|---|---|---|---|
| Package (num) | Per cap | Price | Buy |
| 60 | $0.66 | $39.56 (0%) | 🛒 Add to cart |
| 90 | $0.57 | $59.34 $51.60 (13%) | 🛒 Add to cart |
| 120 | $0.53 | $79.12 $63.64 (20%) | 🛒 Add to cart |
| 180 | $0.49 | $118.68 $87.72 (26%) | 🛒 Add to cart |
| 270 | $0.46 | $178.02 $123.84 (30%) | 🛒 Add to cart |
| 360 | $0.44
Best per cap | $237.36 $159.10 (33%) | 🛒 Add to cart |
Prilosec (omeprazole) is a proton pump inhibitor (PPI) indicated for the short-term treatment of gastroesophageal reflux disease (GERD), including erosive esophagitis, and other acid-related conditions. As a first-in-class medication, it works by directly inhibiting the proton pumps in the stomach lining, the final step of acid production. This guide provides a comprehensive, evidence-based overview for healthcare professionals and informed patients, detailing its mechanism, appropriate use, and essential safety information to support clinical decision-making and patient adherence.
Features
- Active ingredient: Omeprazole (20 mg delayed-release tablets)
- Drug class: Proton pump inhibitor (PPI)
- Formulation: Delayed-release oral tablet, designed to bypass gastric acid
- Mechanism: Irreversibly binds to H+/K+ ATPase enzyme system of gastric parietal cells
- Onset of action: Within 1 hour; full effect may take 1–4 days
- Duration of acid suppression: Up to 72 hours
- Available by prescription and as an over-the-counter (OTC) product for frequent heartburn
Benefits
- Provides profound and prolonged suppression of gastric acid secretion, facilitating healing of erosive esophagitis.
- Effectively reduces the frequency and severity of heartburn and regurgitation symptoms associated with GERD.
- Enables resolution of acid-related damage to the esophageal mucosa, reducing the risk of complications like Barrett’s esophagus.
- Offers convenient once-daily dosing for most indications, supporting high patient compliance.
- Can be used in combination with antibiotics for the eradication of H. pylori in peptic ulcer disease.
- Provides a well-established safety and efficacy profile backed by decades of clinical use and research.
Common use
Prilosec is primarily prescribed for the short-term treatment (4–8 weeks) of active duodenal ulcers, active benign gastric ulcers, erosive esophagitis, and symptomatic GERD. It is also indicated for the maintenance of healing of erosive esophagitis and for pathological hypersecretory conditions such as Zollinger-Ellison syndrome. Furthermore, it is used in triple therapy regimens, combined with antibiotics like amoxicillin and clarithromycin, for the eradication of Helicobacter pylori infection to reduce the risk of ulcer recurrence. The OTC formulation is approved for the self-treatment of frequent heartburn (occurring 2 or more days per week).
Dosage and direction
The recommended adult oral dosage for most GERD and ulcer indications is 20 mg once daily for 4 to 8 weeks. For maintenance healing of erosive esophagitis, 20 mg once daily is typical. For hypersecretory conditions, the dosage must be individualized, often starting at 60 mg once daily and adjusted based on patient response; doses greater than 80 mg should be divided. For H. pylori eradication, a dosage of 20 mg twice daily is used in combination therapy for 10–14 days. Tablets should be swallowed whole with a glass of water before a meal, typically in the morning. The tablets must not be crushed, chewed, or split, as this compromises the enteric coating. For patients with difficulty swallowing, the capsule can be opened and the granules mixed with applesauce or apple juice and swallowed immediately without chewing.
Precautions
Long-term use (e.g., beyond one year) of PPIs like Prilosec requires careful risk-benefit assessment. Patients should be monitored for potential hypomagnesemia, which can present with seizures, arrhythmias, or muscle spasms; magnesium supplementation may be necessary. There is an associated increased risk of bone fractures (hip, wrist, spine) with high-dose, long-term therapy. Patients should be advised to report any new or persistent diarrhea, as Clostridium difficile-associated diarrhea has been reported. Avoid use in patients with suspected gastrointestinal malignancy, as symptom relief may delay diagnosis. Use with caution in patients with hepatic impairment; consider dose adjustment in severe liver disease. Periodic monitoring of vitamin B12 levels may be prudent in patients expected to be on long-term therapy, as acid suppression can impair B12 absorption.
Contraindications
Prilosec is contraindicated in patients with known hypersensitivity to omeprazole, any substituted benzimidazoles, or any component of the formulation. Concomitant use with rilpivirine-containing products is contraindicated due to the potential for decreased rilpivirine concentrations and loss of virologic response. It should not be used in patients taking drugs whose absorption is pH-dependent and for which a significant drug interaction could occur (e.g., certain azole antifungals, see Drug Interactions).
Possible side effect
The most common adverse reactions (≥2%) observed in clinical trials include headache, abdominal pain, nausea, diarrhea, vomiting, and flatulence. Serious side effects, though less common, require immediate medical attention. These include severe diarrhea (possibly C. difficile), acute interstitial nephritis (may present with fever, rash, eosinophilia), cutaneous lupus erythematosus, and systemic lupus erythematosus. Long-term use has been associated with hypomagnesemia, vitamin B12 deficiency, and an increased risk of fractures. Fundic gland polyps have been observed; these are usually benign and asymptomatic.
Drug interaction
Prilosec can alter the absorption or metabolism of concomitant medications due to its profound effect on gastric pH and its metabolism via CYP2C19. It may decrease the absorption of drugs requiring acidic gastric pH for absorption, such as ketoconazole, itraconazole, erlotinib, and mycophenolate mofetil. Conversely, it can increase the absorption of digoxin. As an inhibitor of CYP2C19, it can increase systemic exposure to drugs metabolized by this enzyme, including diazepam, citalopram, and clopidogrel. The interaction with clopidogrel is particularly noteworthy, as omeprazole may reduce its antiplatelet activity; alternative acid-suppression therapy should be considered. It may also increase concentrations of saquinavir and methotrexate.
Missed dose
If a dose is missed, it should be taken as soon as remembered on the same day. However, if it is near the time for the next scheduled dose, the missed dose should be skipped and the regular dosing schedule resumed. Patients should be instructed not to take a double dose to make up for a missed one, as this increases the risk of side effects without enhancing efficacy.
Overdose
Experience with omeprazole overdose is limited. Doses up to 2400 mg have been reported. Manifestations are generally consistent with the known safety profile and may include confusion, drowsiness, blurred vision, tachycardia, nausea, diaphoresis, flushing, headache, and dry mouth. Specific antidotes are not known. Treatment should be supportive and symptomatic. Omeprazole is extensively protein-bound and is therefore not expected to be removed by dialysis.
Storage
Prilosec tablets should be stored at room temperature between 20°C to 25°C (68°F to 77°F), with excursions permitted between 15°C to 30°C (59°F to 86°F). The product must be kept in its original blister pack or bottle to protect it from moisture and light until the moment of use. Keep out of reach of children and pets. Do not use after the expiration date printed on the packaging.
Disclaimer
This information is intended for educational and informational purposes only and does not constitute medical advice. It is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or before starting or stopping any medication. Never disregard professional medical advice or delay in seeking it because of something you have read here. The manufacturer’s official prescribing information should be consulted for complete details.
Reviews
Clinical Efficacy: “In numerous randomized controlled trials, a 20 mg once-daily regimen of omeprazole demonstrated superior healing rates for erosive esophagitis (over 80% at 8 weeks) and complete heartburn resolution compared to H2-receptor antagonists and placebo. Its role in H. pylori eradication therapy remains a cornerstone of modern gastroenterology.” – Journal of Clinical Gastroenterology
Patient Experience: “After years of struggling with severe reflux that disrupted my sleep and diet, a 4-week course of prescription Prilosec provided remarkable relief. The once-daily dosing was easy to remember. I experienced mild headache in the first week, but it subsided.” – Verified Patient, 54
Safety Profile: “While omeprazole is generally well-tolerated for short-term use, our long-term observational data reinforces the need for periodic monitoring of magnesium and vitamin B12 levels in patients on continuous therapy, and a periodic reassessment of the continued need for PPI treatment.” – Pharmacoepidemiology and Drug Safety